- 121MarketSource · Medical Design & Outsourcing
Nelipak reports progress on healthcare packaging sustainability
Nelipak Corporation, a healthcare packaging solutions provider, released its 2025 Sustainability Report detailing progress toward long-term sustainability goals and product innovations. The report aligns with the company's stated vision to support sustainable healthcare practices through packaging solutions.
- 122MarketSource · Medical Device Network
Cardinal Health makes acquisition duo worth $360m for home care business advance
Cardinal Health acquired Strive Medical and Adapt Health's diabetes unit in two deals totaling $360 million to expand its home care business. The acquisitions strengthen Cardinal Health's portfolio in at-home medical device and diabetes management services, supporting its stated growth strategy in the home care sector.
- 123MarketSource · Medical Device Network
Tempus AI acquires Personalis in $1.5bn precision oncology-focused deal
Tempus AI acquired Personalis for $1.5 billion in an all-stock deal focused on precision oncology. Personalis' minimal residual disease (MRD) testing platform will be integrated into Tempus' oncology portfolio, expanding the combined company's diagnostic and data capabilities in cancer care.
- 124MarketSource · MedCity News
Expecting Massive Test Growth in Cancer & More, Tempus AI Strikes $1.5B Deal to Buy Personalis
Tempus AI announced a $1.5 billion acquisition of Personalis, a liquid biopsy company specializing in minimal residual disease (MRD) assays that detect remaining cancer cells after treatment. Tempus has served as the commercial partner for Personalis's MRD test since 2023. The deal consolidates two players in the growing cancer diagnostics market.
- 125MarketSource · Medical Design & Outsourcing
Medline to open new distribution facility in California
Medline announced plans to open a 1-million-square-foot distribution facility in Perris, California, expanding its logistics network following a similar buildout in Texas. The facility is intended to increase capacity and operational flexibility for healthcare providers across the state.
- 126MarketSource · Medical Device Network
British Business Bank commits €25m to EQT Life Sciences’ latest fund
The British Business Bank has committed €25 million to EQT Life Sciences' latest fund. The Bank has prior co-investment experience with EQT portfolio companies Phagenesis and Cyted Health, signaling continued backing of the venture capital firm's life-sciences investments.
- 127MarketSource · Medical Device Network
RapidPulse obtains funding for stroke aspiration system
RapidPulse secured $48 million in funding to advance clinical development of its aspiration technology for acute ischemic stroke treatment. The capital will support the company's efforts to move the system through clinical validation and toward market commercialization.
- 128MarketSource · Medical Device Network
GE and Catholic Health enter $500m alliance to expand diagnostics access
GE HealthCare and Catholic Health have formed a 10-year strategic alliance valued at approximately $500 million to expand precision diagnostics, advanced imaging, and AI-supported technology across Catholic Health's Long Island network. The partnership aims to increase access to diagnostic capabilities and modernize imaging infrastructure within the health system.
- 129MarketSource · Medical Device Network
DePuy Synthes expands spine portfolio after Expanding Innovations acquisition
DePuy Synthes acquired Expanding Innovations, gaining access to the company's interbody cage systems for complex spinal surgery. The deal expands DePuy Synthes' spine portfolio.
- 130MarketSource · Medical Device Network
Neko Health raises $700m as US market entry draws closer
Neko Health secured $700 million in funding as the Swedish health-screening company prepares to enter the US market with its first location in New York this year, followed by additional US sites. The funding round supports the company's expansion beyond its existing Scandinavian operations into the American medical-device and diagnostic-screening sector.
- 131MarketSource · Medical Device Network
BIOTRONIK Neuro acquires Soin Neuroscience’s SCS IP portfolio
BIOTRONIK Neuro has acquired an intellectual property portfolio from Soin Neuroscience focused on spinal cord stimulation (SCS) technology. The deal expands BIOTRONIK's neuromodulation capabilities and IP footprint in the SCS market.
- 132MarketSource · MedCity News
Neko Health Secures $700M to Support US Expansion
Neko Health secured $700 million in Series C funding co-led by Lightspeed Venture Partners and O.G. Venture Partners to support US expansion. The round included participation from Atomico, General Catalyst, Lakestar, Liberty City Ventures, Positive Sum, and BDT & MSD. Neko operates diagnostic imaging and health-screening services, positioning itself as a vendor in the preventive diagnostics and mobile imaging space.
- 133MarketSource · Medical Device Network
J&J raises FY26 outlook following positive Q2
Johnson & Johnson raised its fiscal 2026 outlook following strong second-quarter results, with MedTech contributing $8.9 billion of the division's $25.3 billion in total Q2 revenues. Growth was driven in part by its cardiovascular portfolio, including the Shockwave IVL lithotripsy system.
- 134MarketSource · Medical Device Network
Women’s health attracted record equity in 2025 as companies share capital
Women's health companies attracted record equity funding in 2025 as investors increased capital allocation to the sector. The surge reflects growing recognition that closing gender health gaps could add over $1 trillion annually to the global economy by 2040, driving venture and growth capital toward female-focused medical device and diagnostic companies.
- 135MarketSource · Medical Device Network
THINK Surgical nets up to $65m with Symbiotic Capital debt facility
Think Surgical secured a debt facility of up to $65 million from Symbiotic Capital. The company's flagship product is TMINI, a handheld robotic system for total knee arthroplasty procedures. The financing will support the company's operations and growth.
- 136MarketSource · Medical Device Network
Neuraptive secures exclusive licence from Washington University for nerve device
Neuraptive Therapeutics has secured an exclusive licence from Washington University in St. Louis for a bioresorbable wireless electronic stimulation device designed for peripheral nerve repair. The deal grants Neuraptive rights to commercialize the technology, which represents a strategic licensing partnership in the neurology device space.
- 137MarketSource · Medical Design & Outsourcing
Ultrasound CDMO Vermon opens new plant and buys subsystem specialist
Vermon, a Tours, France-based ultrasound contract manufacturer, opened a new 30,000-square-foot TransducerWorks facility in Pennsylvania—four times larger than its predecessor and equipped with ISO 7 and ISO 8 cleanrooms and integrated machine shop—and acquired Modeleus, an OEM ultrasound subsystem specialist, to establish the Vermon Group platform.
- 138MarketSource · Medical Device Network
Edwards Lifesciences served $10m penalty over JC Medical acquisition violations
Edwards Lifesciences was ordered to pay a $10 million penalty after a court found the company violated antitrust law requirements in its 2024 acquisition of JC Medical. The FTC enforcement action followed a ruling that Edwards failed to comply with merger conditions.
- 139MarketSource · Medical Design & Outsourcing
Nitinol supplier Fort Wayne Metals sold
Axel Johnson Inc. has acquired Fort Wayne Metals and its parent company Fort Wayne Metals Research Products. The nitinol supplier, founded in 1970 and based in Fort Wayne, Indiana, will remain headquartered at its current location under new ownership. Financial terms were not disclosed.
- 140MarketSource · Medical Device Network
En Carta secures $6.18m to expand molecular testing solutions
En Carta Diagnostics closed €5 million ($6.18 million) in funding to expand its at-home molecular diagnostic solutions. The financing will support scaling of the company's testing platform for consumers and clinical applications.
- 141MarketSource · Medical Device Network
Virax Biolabs enters immune profiling product supply deal with Fosun
Virax Biolabs signed an exclusive commercial supply agreement with Fosun Diagnostics to distribute its ImmuneSelect immune profiling product line. The deal covers research-use-only applications of the immune profiling platform.
- 142MarketSource · Medical Device Network
Otsuka ICU Medical outlays $500m to expand US manufacturing footprint
Otsuka ICU Medical announced a $500 million investment to expand its US manufacturing capacity, including construction of a new facility and upgrades to its existing Austin, Texas site. The expansion reflects the company's commitment to domestic production and supply-chain resilience for its medical device portfolio.
- 143MarketSource · MedCity News
IKS Health Beefs Up Its Tech Stack with $557M Acquisition of TruBridge
IKS Health acquired TruBridge for $557 million, integrating the EHR and revenue-cycle management vendor into its AI-powered care platform. The deal marks IKS Health's third acquisition in 2026 and expands its footprint in rural-hospital IT services.
- 144MarketSource · Medical Device Network
GE HealthCare and Mayo Clinic partner for new theranostics research study
GE HealthCare and Mayo Clinic have announced a partnership to conduct a theranostics research study focused on radioligand therapy. The collaboration will evaluate how imaging and biomarker data can inform personalized treatment approaches using RLT, combining diagnostic insights with targeted therapeutic delivery.
- 145MarketSource · Medical Device Network
Leo Cancer Care raises $65m for upright radiotherapy platform
Leo Cancer Care raised $65 million in funding for its Marie radiotherapy platform, an upright positioning system paired with CT imaging for proton therapy delivery. The system received FDA clearance in July 2025. The funding supports commercialization of the platform, which addresses workflow and patient positioning in radiation oncology.
- 146MarketSource · Medical Device Network
Resmed sharpens sleep care focus with $490m software business sale
ResMed sold MatrixCare, its software business, to private-equity firm Frazier Healthcare Partners for $490 million, less than a decade after acquiring it for $750 million. The divestment reflects ResMed's strategic pivot to concentrate on its core sleep and respiratory care device portfolio.
- 147MarketSource · Medical Device Network
Ottobock expands neuro-orthotics portfolio with Fesia Technology acquisition
Ottobock acquired Fesia Technology to expand its neuro-orthotics offerings. The deal brings Fesia's portfolio of functional electrical stimulation (FES) products used in neurorehabilitation into Ottobock's product line, strengthening its position in the neurological rehabilitation device market.
- 148MarketSource · Medical Device Network
VB Spine to acquire rights to Augmedics’ CT-Fluoro technology
VB Spine has signed a definitive agreement to acquire exclusive rights to Augmedics' CT-Fluoro technology for spine surgery applications. CT-Fluoro combines computed tomography and fluoroscopy imaging to guide surgical procedures. The acquisition expands VB Spine's intraoperative imaging portfolio for spinal intervention.
- 149MarketSource · Medical Device Network
Alcon spends up to $200m to co-develop customisable cataract lenses with RxSight
Alcon and RxSight announced a co-development partnership valued at up to $200 million to create a tunable presbyopia-correcting intraocular lens (PCIOL) for cataract patients. The collaboration combines Alcon's surgical expertise with RxSight's light-adjustable lens technology to deliver customizable vision correction after implantation.
- 150MarketSource · Medical Device Network
Zydus and Apollo Hospitals sign MoU to launch MCD test in India
Zydus Lifesciences and Apollo Hospitals signed a memorandum of understanding to expand access to Shield, a multi-cancer detection test, across Apollo's hospital network in India. The partnership aims to broaden availability of the cancer screening diagnostic in the Indian market.
- 151MarketSource · Medical Device Network
Vivani strikes reverse-merger agreement with ClearOne for BCI business
Vivani Medical has entered a reverse-merger agreement with ClearOne, combining its brain-computer interface (BCI) business with ClearOne to create a publicly listed entity. Upon completion, the combined company will be renamed Cortigent Holdings and will trade on Nasdaq, providing Vivani's BCI technology with public market access.
- 152MarketSource · Medical Design & Outsourcing
Zimmer Biomet is adding hundreds of tech jobs in India
Zimmer Biomet plans to hire 500 technical professionals over three years at a new tech center in Bengaluru, India. Positions include software engineering, product design, R&D, quality, regulatory, and finance roles. The expansion reflects the orthopedic and spine device maker's strategy to build engineering and innovation capacity in lower-cost markets.
- 153MarketSource · Medical Device Network
Materna Medical raises $5m for women’s health device portfolio
Materna Medical closed a $5 million funding round to advance its women's health device portfolio. The capital will fund completion of a pivotal trial for its pelvic floor protection system during childbirth, alongside commercial expansion efforts.
- 154MarketSource · Medical Device Network
Zimmer Biomet to acquire iovera device from Pacira for $140m
Zimmer Biomet agreed to acquire Pacira BioSciences' iovera device, a drug-free pain management system, for up to $140 million. The transaction expands Zimmer Biomet's portfolio in the orthopedic and pain-relief device space.
- 155MarketSource · Medical Design & Outsourcing
High-precision stainless steel tubing supplier M&M International buys KC Tech
M&M International, a New Jersey-based supplier of high-precision stainless steel tubing for medical devices, has acquired KC Tech. M&M, founded in 1993, manufactures 304, 316-grade, and 17-7 stainless steel small-diameter tubing and operates manufacturing facilities in South Korea. The deal consolidates two suppliers serving the medical device sector.
- 156MarketSource · Medical Design & Outsourcing
Ex-Medtronic CEO Bill Hawkins joins Ketryx board
Bill Hawkins, retired Medtronic chair and CEO, has joined the board of Ketryx, a regulatory software platform for life sciences companies. Hawkins noted in a statement that medtech leaders are seeking ways to leverage AI to accelerate safe innovation, signaling growing industry interest in regulatory automation tools.
- 157MarketSource · Medical Device Network
Merck KGaA to buy Bio-Techne for $11.3bn in life science footprint expansion
Merck KGaA announced an $11.3 billion acquisition of Bio-Techne, a life sciences company, marking its largest deal since the 2015 purchase of Sigma-Aldrich for $17 billion. The transaction expands Merck's portfolio in research reagents, instruments, and related life science tools supplied to labs and medical institutions.
- 158MarketSource · Medical Device Network
Advanced Medical Solutions mulls £715m HB Fuller takeover bid
Advanced Medical Solutions is considering a £715 million acquisition of HB Fuller, which the companies say would expand the combined addressable market by $15 billion and add approximately $300 million in annual revenue. The deal represents a significant consolidation move within the medical equipment and supplies sector.
- 159MarketSource · Medical Device Network
Tissium wins €60m to bring sutureless nerve repair system to market
Tissium secured €60 million in financing to commercialize COAPTIUM CONNECT, a sutureless peripheral nerve repair surgical system, in the US market. The device represents a new approach to nerve repair that avoids traditional suturing techniques.
- 160MarketSource · MedCity News
Cadence Rakes In $100M to Automate Chronic Care at Scale
Cadence, an AI-powered chronic care platform, raised $100 million in Series C funding at a $1.23 billion valuation. The company's software monitors patients at home and adjusts medications in real time for heart failure, hypertension, and diabetes management through partnerships with health systems.